TCTR20210704002尚未招募4 期
Efficacy of intralesional botulinum toxin injection in nail psoriasis patients: A Double-blinded Randomized Controlled Trial
Chulabhorn International College of Medicine, Thammasat University0 个研究点目标入组 18 人开始时间: 2021年7月4日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1. Patient aged at least 20 years old.
- •2. Psoriatic nail patients who have at least 4 psoriatic nails.
- •3. Each enrolled nail has target NAPSI score at least 3 points.
排除标准
- •1. Patients refusel to participate the study
- •2. Patients are using topical nail therapies within 2 weeks.
- •3. Patients are receiving oral therapies within 4 weeks.
- •4. Patients have active nail infection.
- •5. Patient with sensitivity or allergy to constituents of the botulinum toxin product, vitamin D , corticosteroid, cows milk protein or lidocaine
- •6. Patient with neuromuscular disorder or peripheral motor neuropathic disease (e.g. amyotrophic lateral sclerosis, myasthenia gravis, Lambert Eaton syndrome, myopathies)
- •7. Pregnancy or breastfeeding
- •8. Unrealistic expectation
研究者
相似试验
进行中（未招募）
1 期
Evaluation of botulinum toxin injection efficacy in the treatment of head essential tremorEUCTR2015-000162-59-FRCHU Clermont-Ferrand120
进行中（未招募）
1 期
Botox injection in 1st toe to treat spasticityThe application of Botox is described in the technical sheet for spasticity and has already been applied to the foot. This is how we speak of a phase IV clinical trial, with a low level of intervention.EUCTR2020-005653-24-ESClínica Integral del pie-Ana Sans120
已完成
不适用
Safety and efficacy of botulinum toxin injection therapy on patients with esophageal motility disordersEsophageal motility disorders except for achalasiaJPRN-UMIN000021190Gunma University Hospital5
尚未招募
不适用
De effectiviteit van botuline toxine A als injectie in de bekkenbodemspier bij patiënten met chronische bekkenpijn: een dubbel-geblindeerde, gerandomiseerde studie.chronic pelvic pain with pelvic floor hypertonicityNL-OMON20966Radboudumc, Nijmegen92
进行中（未招募）
1 期
The efficacy of botulin toxin A injection in the pelvic floor muscles in the treatment of chronic pelvic pain.Patients with >6 months or recurrent episodes of abdomino-perineo-pelvic pain, hypersensitivity or discomfort often associated with elimination changes, and sexual dysfunction in the absence of organic etiology (definition of the International Continence Society (ICS)) with (primary of secondary) pelvic floor muscle hypertonicity refractory to first line pelvic floor physiotherapy, willing to participate in this trial.EUCTR2017-001296-23-NLRadboudumc92